GE HealthCare

GE HealthCare, a US-based company in the Medical, precision and optical instruments, watches and clocks industry, is committed to addressing its carbon emissions.

For 2024, GE HealthCare reported total emissions of approximately 6.045 billion kg CO2e. This included Scope 1 emissions of 105 million kg CO2e, Scope 2 (market-based) emissions of 116 million kg CO2e, and Scope 3 emissions of approximately 5.707 billion kg CO2e. Key contributors to Scope 3 emissions were use of sold products (approximately 3.599 billion kg CO2e), purchased goods and services (approximately 1.082 billion kg CO2e), and upstream transportation and distribution (584 million kg CO2e).

Looking ahead to 2025, GE HealthCare projects a reduction in total emissions to approximately 5.915 billion kg CO2e. This projection includes Scope 1 emissions of 103.858 million kg CO2e, Scope 2 (market-based) emissions of 97.699 million kg CO2e, and Scope 3 emissions of approximately 5.566 billion kg CO2e.

Historical data shows total reported emissions of approximately 6.5 billion kg CO2e in 2022 and approximately 6.8 billion kg CO2e in 2021. In 2020, total Scope 1 and 2 (market-based) emissions were approximately 294.042 million kg CO2e, and in 2019, they were approximately 329.461 million kg CO2e.

GE HealthCare has set ambitious climate commitments. The company aims to achieve net-zero greenhouse gas emissions across its entire value chain by 2050. As part of its near-term targets, the company, with its ultimate parent GE HealthCare Technologies Inc. setting the targets, commits to reducing absolute Scope 1 and 2 GHG emissions by 42% by 2030 from a 2022 base year. Additionally, it aims to reduce absolute Scope 3 GHG emissions from purchased goods and services, upstream transportation and distribution, business travel, and use of sold products by 25% by 2030, also from a 2022 base year. These targets are validated by the Science Based Targets initiative (SBTi) as consistent with a 1.5°C warming scenario.